Luke Combs has lost 30 lbs. on his weight loss journey. Here’s everything to know about Luke Combs' weight loss.

As you begin to see the number on the scale drop and your running improve, it’s easy to fall into a trap: associating that ...

Never underestimate the power of a brisk walk. The CDC recommends taking a stroll for 30 minutes a day, five days a week. The ...

If you found this video enjoyable, kindly show your support by giving it a thumbs up, leaving a comment, and subscribing for future content. ✏️ Featuring our excellent speakers that will give you that ...

Her candid admission about menopause struggles and GLP-1 medication collides with a viral side-by-side post questioning whether extreme thinness reflects […] The post Vanessa Williams’ weight loss ...

RHOSLC star Heather Gay opens up about weight loss journey, cosmetic procedures she's had, using GLP-1s and more ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. The launch this week of an oral pill version of Wegovy ...

If you’re looking to create a healthier lifestyle, look no further than the power of running. Movement makes up a portion of the weight loss puzzle, and with our new Running for Weight Loss program, ...

Share on Pinterest The Food and Drug Administration (FDA) recently approved a tablet version of the GLP-1 drug Wegovy for weight loss. Image courtesy of Novo Nordisk Novo Nordisk officials said a new ...

A pill form of weight-loss drug Wegovy, manufactured by Danish drugmaker Novo Nordisk, is now available in the U.S., giving Americans access to an oral medication to treat obesity. The starting dose ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new ...

GLP-1 medications have dominated the weight-loss landscape this year — but some older Americans are reportedly kicking the trend to the curb. A study published in JAMA in January 2025 — which looked ...